XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Millions
3 Months Ended 9 Months Ended
Jul. 04, 2025
Jun. 28, 2024
Jul. 04, 2025
Jun. 28, 2024
Income Statement [Abstract]        
Revenues, net $ 203,000,000.0 $ 209,100,000 $ 615,700,000 $ 605,300,000
Cost of revenues 135,500,000 142,200,000 403,000,000.0 415,500,000
Gross profit 67,500,000 66,900,000 212,700,000 189,800,000
Operating expenses:        
Research and development 21,400,000 22,000,000.0 66,900,000 65,100,000
Selling, general, and administrative 32,900,000 35,600,000 99,300,000 103,500,000
Impairment of goodwill 93,900,000 0 93,900,000 0
Total operating expenses 148,200,000 57,600,000 260,100,000 168,600,000
Operating (loss) income (80,700,000) 9,300,000 (47,400,000) 21,200,000
Interest income 2,500,000 1,800,000 7,500,000 5,500,000
Interest expense (9,400,000) (7,400,000) (27,600,000) (22,600,000)
Other income (expense), net 1,000,000.0 (2,900,000) (5,800,000) (1,600,000)
Interest and other expense, net (5,900,000) (8,500,000) (25,900,000) (18,700,000)
(Loss) income before taxes (86,600,000) 800,000 (73,300,000) 2,500,000
Income tax expense (benefit) 2,500,000 (700,000) 8,800,000 (200,000)
Net (loss) income (89,100,000) 1,500,000 (82,100,000) 2,700,000
Less: Net income attributable to noncontrolling interests 0 100,000 400,000 400,000
Net (loss) income attributable to Varex $ (89,100,000) $ 1,400,000 $ (82,500,000) $ 2,300,000
Net (loss) income per common share attributable to Varex        
Basic (in USD per share) $ (2.15) $ 0.03 $ (2.00) $ 0.06
Diluted (in USD per share) $ (2.15) $ 0.03 $ (2.00) $ 0.06
Weighted average common shares outstanding        
Basic (in shares) 41.5 40.9 41.3 40.7
Diluted (in shares) 41.5 41.2 41.3 41.2